These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14727885)

  • 1. Physical and chemical permeation enhancers in transdermal delivery of terbutaline sulphate.
    Murthy SN; Hiremath SR
    AAPS PharmSciTech; 2001 Feb; 2(1):E-TN1. PubMed ID: 14727885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
    Narishetty ST; Panchagnula R
    Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of carboxymethyl guar films for the formulation of transdermal therapeutic systems.
    Narasimha Murthy S; Hiremath SR; Paranjothy KL
    Int J Pharm; 2004 Mar; 272(1-2):11-8. PubMed ID: 15019064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins.
    Panigrahi L; Pattnaik S; Ghosal SK
    AAPS PharmSciTech; 2005 Sep; 6(2):E167-73. PubMed ID: 16353974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxypropylmethylcellulose films for prolonged delivery of the antipsychotic drug chlorpromazine.
    Luppi B; Bigucci F; Baldini M; Abruzzo A; Cerchiara T; Corace G; Zecchi V
    J Pharm Pharmacol; 2010 Mar; 62(3):305-9. PubMed ID: 20487212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of enhancers for transdermal drug delivery.
    Mitragotri S
    Pharm Res; 2000 Nov; 17(11):1354-9. PubMed ID: 11205727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of iontophoresis and permeation enhancers on the permeation of an acyclovir gel.
    Vaghani SS; Gurjar M; Singh S; Sureja S; Koradia S; Jivani NP; Patel MM
    Curr Drug Deliv; 2010 Oct; 7(4):329-33. PubMed ID: 20695844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terbutaline transdermal delivery: preformulation studies and limitations of in-vitro predictive parameters.
    Tenjarla S; Puranajoti P; Kasina R; Mandal T
    J Pharm Pharmacol; 1996 Nov; 48(11):1138-42. PubMed ID: 8961161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal drug delivery: penetration enhancement techniques.
    Benson HA
    Curr Drug Deliv; 2005 Jan; 2(1):23-33. PubMed ID: 16305405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques.
    Agyralides GG; Dallas PP; Rekkas DM
    Int J Pharm; 2004 Aug; 281(1-2):35-43. PubMed ID: 15288341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of component of microemulsion for transdermal delivery of nicardipine hydrochloride.
    Wu PC; Lin YH; Chang JS; Huang YB; Tsai YH
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1398-403. PubMed ID: 20545507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical optimization of transdermal drug delivery system of terbutaline sulfate by factorial analysis.
    Manna A; Ghosh I; Sen N; Thakur RS; Ghosh LK; Gupta BK
    Boll Chim Farm; 2000; 139(1):34-40. PubMed ID: 10829551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration enhancers.
    Williams AC; Barry BW
    Adv Drug Deliv Rev; 2004 Mar; 56(5):603-18. PubMed ID: 15019749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl.
    Karakatsani M; Dedhiya M; Plakogiannis FM
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1195-206. PubMed ID: 20545504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin electroporation for transdermal and topical delivery.
    Denet AR; Vanbever R; Préat V
    Adv Drug Deliv Rev; 2004 Mar; 56(5):659-74. PubMed ID: 15019751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action.
    Novotný M; Klimentová J; Janůšová B; Palát K; Hrabálek A; Vávrová K
    J Control Release; 2011 Mar; 150(2):164-70. PubMed ID: 21093505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.